Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
BJU International|September 19, 2017
Guideline of guidelines: asymptomatic microscopic haematuriaBrian J Linder, Edward J Bass, Hugh Mostafid, et al.
European Urology|December 3, 2014
Therapeutic options in high-risk non-muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-GuérinA Hugh Mostafid, Joan Palou Redorta, Richard Sylvester, et al.
BJU International|February 14, 2006
Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancerA Hugh Mostafid, Raj G N Rajkumar, Alistair B Stewart, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 13, 2018
Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer PatientsJoep J de Jong, Kees Hendricksen, Marloes Rosier, et al.
Frontiers in Surgery|June 17, 2021
En Bloc Resection of Bladder Tumor-Is It the Way Forward?Christian Daniel Fankhauser, Marian Severin Wettstein, Luca Afferi, et al.
BJU International|December 15, 2018
Urothelial cancer: a narrative review of the role of novel immunotherapeutic agents with particular reference to the management of non-muscle-invasive diseaseEmma Doyle, Jeremy Crew, Hugh Mostafid, et al.
Seminars in Oncology Nursing|August 11, 2020
Indications and Complications of Androgen Deprivation TherapyChristian Daniel Fankhauser, Marian Severin Wettstein, Michèle Reinhardt, et al.
The Journal of Urology|May 2, 2019
Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder CancerMaxwell V Meng, Jürgen E Gschwend, Neal Shore, et al.
World Journal of Urology|March 28, 2021
En-bloc resection of bladder tumour as primary treatment for patients with non-muscle-invasive bladder cancer: routine implementation in a multi-centre settingJeremy Yuen-Chun Teoh, Nikhil Mayor, Kai-Man Li, et al.
European Urology Oncology|November 16, 2024
Unmet Need in Non-muscle-invasive Bladder Cancer Failing Bacillus Calmette-Guérin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer GroupDavid D'Andrea, Hugh Mostafid, Paolo Gontero, et al.
Pageof 7